Alpha 2.0
Login Register
» Authors » F Carbonnel

F Carbonnel

Explore the profile of F Carbonnel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 4816
Followers 0
Related Specialties
Gastroenterology
Oncology
Pharmacology
Top 10 Co-Authors
J Cosnes
L Beaugerie
J P Gendre
Y LE QUINTREC
C Robert
Y Ngo
M Malafosse
L Marthey
M Lemann
W Rozenbaum
Published In
Gastroenterol Clin Biol
Aliment Pharmacol Ther
Ann Oncol
Gut
Ann Gastroenterol Hepatol (Paris)
Affiliations
Soon will be listed here.
Recent Articles
1.
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Haanen J, Obeid M, Spain L, Carbonnel F, Wang Y, Robert C, et al.
Ann Oncol . 2022 Oct; 33(12):1217-1238. PMID: 36270461
No abstract available.
2.
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]
Moreau J, Hammoudi N, Marthey L, Trang-Poisson C, Nachury M, Altwegg R, et al.
J Crohns Colitis . 2020 Sep; 15(3):432-440. PMID: 32969469
Background: Better patient knowledge on inflammatory bowel disease [IBD] could improve outcome and quality of life. The aim of this study was to assess if an education programme improves IBD...
3.
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, et al.
Ann Oncol . 2019 Aug; 30(12):2012. PMID: 31408090
No abstract available.
4.
Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort
Matejcic M, Lesueur F, Biessy C, Renault A, Mebirouk N, Yammine S, et al.
Int J Cancer . 2018 Aug; 143(10):2437-2448. PMID: 30110135
There are both limited and conflicting data on the role of dietary fat and specific fatty acids in the development of pancreatic cancer. In this study, we investigated the association...
5.
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Haanen J, Carbonnel F, Robert C, Kerr K, Peters S, Larkin J, et al.
Ann Oncol . 2018 Jun; 29(Suppl 4):iv264-iv266. PMID: 29917046
No abstract available.
6.
Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies
Collins M, Michot J, Danlos F, Mussini C, Soularue E, Mateus C, et al.
Ann Oncol . 2017 Oct; 28(11):2860-2865. PMID: 29045560
Background: Immune check-point blockade agents have shown clinical activity in cancer patients but are associated with immune-related adverse events that could limit their development. The aim of this study was...
7.
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Haanen J, Carbonnel F, Robert C, Kerr K, Peters S, Larkin J, et al.
Ann Oncol . 2017 Sep; 28(suppl_4):iv119-iv142. PMID: 28881921
No abstract available.
8.
Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan-authors'reply
Marthey L, Carbonnel F
Aliment Pharmacol Ther . 2017 Jul; 46(4):473-474. PMID: 28707797
No abstract available.
9.
No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC)
Bergmann M, Hernandez V, Bernigau W, Boeing H, Chan S, Luben R, et al.
Eur J Clin Nutr . 2017 Apr; 71(4):566. PMID: 28377581
No abstract available.
10.
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, et al.
Ann Oncol . 2017 Apr; 28(6):1368-1379. PMID: 28368458
Background: Ipilimumab, an immune checkpoint inhibitor targeting CTLA-4, prolongs survival in a subset of patients with metastatic melanoma (MM) but can induce immune-related adverse events, including enterocolitis. We hypothesized that...